Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!
ARKG Investment Tracker position change: Decreased position in Veeva by 336 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 0.7% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 27,594 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 13,314 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.27% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 371 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 1.1% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 217 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 1,134 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.06% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 1,715 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.7% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 41,692 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.56% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 17,969 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.92% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 93,387 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.79% of the total position.
ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 52,094 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.06% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 17,717 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.92% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 3,360 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.4% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 18,815 shares, the number of shares held decreased 0.63% compared to the previous period and now represents 2.63% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 9,177 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 3.55% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 1,974 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 4.23% of the total position.
ARKQ Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 10,986 shares, the number of shares held increased 0.63% compared to the previous period and now represents 10.91% of the total position.
ARKX Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 14,260 shares, the number of shares held increased 2.47% compared to the previous period and now represents 12.14% of the total position.
ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 117,840 shares, the number of shares held increased 0.55% compared to the previous period and now represents 0.62% of the total position.
ARKX Investment Tracker position change: Increased position in Taiwan Semiconductor Manufacturing by 490 shares, the number of shares held increased 2.45% compared to the previous period and now represents 1.17% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 93,387 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 1.79% of the total position.
ARKG Investment Tracker position change: Decreased position in Atai Beckley Inc by 27,594 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.91% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 217 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 0.89% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 13,314 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.27% of the total position.
ARKW Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 663 shares, the number of shares held decreased 0.36% compared to the previous period and now represents 3.18% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 336 shares, the number of shares held decreased 0.82% compared to the previous period and now represents 0.7% of the total position.
ARKK Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 113,240 shares, the number of shares held increased 0.55% compared to the previous period and now represents 1.31% of the total position.
ARKK Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 4,990 shares, the number of shares held increased 0.55% compared to the previous period and now represents 1.47% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 101,633 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 4.28% of the total position.
ARKK Investment Tracker position change: Increased position in Taiwan Semiconductor Manufacturing by 1,710 shares, the number of shares held increased 0.55% compared to the previous period and now represents 1.4% of the total position.
ARKQ Investment Tracker position change: Increased position in Taiwan Semiconductor Manufacturing by 984 shares, the number of shares held increased 0.63% compared to the previous period and now represents 2.7% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 17,969 shares, the number of shares held decreased 0.83% compared to the previous period and now represents 2.92% of the total position.
ARKQ Investment Tracker position change: Increased position in L3Harris Technologies, Inc. by 1,040 shares, the number of shares held increased 0.63% compared to the previous period and now represents 2.95% of the total position.
ARKX Investment Tracker position change: Increased position in L3Harris Technologies, Inc. by 4,110 shares, the number of shares held increased 2.48% compared to the previous period and now represents 9.97% of the total position.
ARKQ Investment Tracker position change: Increased position in Palantir Technologies Inc. by 3,436 shares, the number of shares held increased 0.63% compared to the previous period and now represents 5.1% of the total position.
ARKK Investment Tracker position change: Increased position in Palantir Technologies Inc. by 8,250 shares, the number of shares held increased 0.55% compared to the previous period and now represents 3.64% of the total position.